Latest Publications

Journal publication
Ahmed Seddik, Ahmed Seddik, Claudio Schneider, In collaboration with Dr. Jasper Huels (Novartis), In collaboration with Dr. Zaza Katsarava (University of Duisburg-Essen), In collaboration with Sara Schramm (University of Duisburg-Essen), Prof. Dr. Dennis Ostwald

Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort Approach

Study
BDI (Editor), WifOR Institute

Economic Impact of the Health Economy Cluster in Hamburg

Methodological paper
Dr. Katharina Zubrzycki, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Kurt Somweber, Nora Albu, Prof. Dr. Dennis Ostwald

Direct Gross Value Added Calculation Method

Library

Journal publication

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

In collaboration with Afschin Gandjour (Frankfurt School of Finance & Management), Prof. Dr. Dennis Ostwald
Journal publication

A case study applying a novel approach to estimate the social impact of a medical innovation – the use of secukinumab for psoriatic arthritis in Germany

Dr. Malina Müller, In collaboration with Bintu Sherif (RTI HS), Prof. Dr. Dennis Ostwald, Sebastian Himmler
Journal publication

The societal impact of Erenumab in prophylactic treatment of patients with migraine in Germany: a macroeconomic open-cohort approach

Ahmed Seddik, Ahmed Seddik, Claudio Schneider, In collaboration with Dr. Jasper Huels (Novartis), Jennifer Branner, Prof. Dr. Dennis Ostwald
Journal publication

German cost analysis of triplet regimens for relapsed or refractory multiple myeloma patients

Dr. Arpit Misra, Dr. Mathias Kappel, In collaboration with Boris A. Ratsch (Takeda), In collaboration with Edin Basic (Takeda), Janine Pöpper, Prof. Dr. Dennis Ostwald
Study

The Social Impact of Novartis medicines: Two Case Studies from South Africa and Kenya

Ahmed Seddik, Ahmed Seddik, Jennifer Branner, Prof. Dr. Dennis Ostwald, Remon Helmy
Study

The Environmental Impact of Novartis Along Global Supply Chains

Dr. Marcus Cramer, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Natalia Benke, Nora Albu, Prof. Dr. Dennis Ostwald

Interested in our newsletter?

Sign Up Here

Interested in our newsletter?